Euroapi SAS (EAPI) - Total Assets
Based on the latest financial reports, Euroapi SAS (EAPI) holds total assets worth €1.24 Billion EUR (≈ $1.45 Billion USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Euroapi SAS - Total Assets Trend (2019–2025)
This chart illustrates how Euroapi SAS's total assets have evolved over time, based on quarterly financial data. Also see EAPI market cap overview for the company's overall valuation and market capitalisation.
Euroapi SAS - Asset Composition Analysis
Current Asset Composition (December 2025)
Euroapi SAS's total assets of €1.24 Billion consist of 58.9% current assets and 41.1% non-current assets. Review EAPI total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €113.80 Million | 8.7% |
| Accounts Receivable | €114.90 Million | 8.8% |
| Inventory | €495.20 Million | 38.0% |
| Property, Plant & Equipment | €486.60 Million | 37.3% |
| Intangible Assets | €26.70 Million | 2.1% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2019–2025)
This chart illustrates how Euroapi SAS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Euroapi SAS stock price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Euroapi SAS's current assets represent 58.9% of total assets in 2025, a decrease from 61.8% in 2019.
- Cash Position: Cash and equivalents constituted 8.7% of total assets in 2025, up from -1.3% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 38.0% of total assets.
Euroapi SAS Competitors by Total Assets
Key competitors of Euroapi SAS based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.01 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Piramal Pharma Limited
NSE:PPLPHARMA
|
India | Rs179.65 Billion |
|
Harbin Gloria Pharmaceuticals
SHE:002437
|
China | CN¥3.14 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
Euroapi SAS - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.01 | 2.53 | 3.12 |
| Quick Ratio | 0.58 | 0.80 | 1.21 |
| Cash Ratio | 0.00 | 0.17 | 0.00 |
| Working Capital | €365.30 Million | €476.00 Million | €661.50 Million |
Euroapi SAS - Advanced Valuation Insights
This section examines the relationship between Euroapi SAS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.10 |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | -12.4% |
| Total Assets | €1.30 Billion |
| Market Capitalization | $81.43 Million USD |
Valuation Analysis
Below Book Valuation: The market values Euroapi SAS's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Euroapi SAS's assets decreased by 12.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Euroapi SAS (2019–2025)
The table below shows the annual total assets of Euroapi SAS from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €1.30 Billion ≈ $1.53 Billion |
-12.41% |
| 2024-12-31 | €1.49 Billion ≈ $1.74 Billion |
-7.62% |
| 2023-12-31 | €1.61 Billion ≈ $1.89 Billion |
-7.13% |
| 2022-12-31 | €1.74 Billion ≈ $2.03 Billion |
+7.27% |
| 2021-12-31 | €1.62 Billion ≈ $1.89 Billion |
+1.09% |
| 2020-12-31 | €1.60 Billion ≈ $1.87 Billion |
+1.54% |
| 2019-12-31 | €1.58 Billion ≈ $1.84 Billion |
-- |
About Euroapi SAS
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that use solid phase chemistry; … Read more